MoneyTreeTM: Quarterly rebound
Venture capital (VC) funding in the life sciences sector, which includes the biotechnology and medical device industries, captured the highest total of VC dollars invested during the second quarter of 2010. Our report, Quarterly Rebound, includes data from the PwC/NVCA MoneyTree Report, based on data from Thomson Reuters. Life sciences funding for Q2 2010 totaled $2.1 billion in 234 deals, which represents an increase of 52% in dollars and a 36% increase in deals from the prior quarter, reversing the performance seen in the first quarter of 2010 when sector investment dropped 27% in dollars and 15% in deals from Q4 2009.
Look for papers, articles, and case studies. See all thought leadership.